| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemangioma | 34 | 2022 | 737 | 6.120 |
Why?
|
| Endothelial Cells | 51 | 2024 | 3455 | 4.470 |
Why?
|
| Sturge-Weber Syndrome | 5 | 2024 | 91 | 3.380 |
Why?
|
| Capillaries | 11 | 2024 | 774 | 3.120 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 6 | 2024 | 140 | 2.950 |
Why?
|
| Neovascularization, Physiologic | 19 | 2019 | 1350 | 2.950 |
Why?
|
| Endothelium, Vascular | 34 | 2022 | 4455 | 2.490 |
Why?
|
| Vascular Malformations | 9 | 2024 | 450 | 2.120 |
Why?
|
| Stem Cells | 23 | 2015 | 3563 | 2.030 |
Why?
|
| Mesenchymal Stem Cells | 12 | 2017 | 1625 | 1.970 |
Why?
|
| Neovascularization, Pathologic | 20 | 2022 | 2633 | 1.910 |
Why?
|
| Mitral Valve | 13 | 2022 | 1484 | 1.900 |
Why?
|
| Epithelial-Mesenchymal Transition | 9 | 2023 | 713 | 1.820 |
Why?
|
| Neoplastic Stem Cells | 14 | 2022 | 1376 | 1.720 |
Why?
|
| Vascular Endothelial Growth Factor A | 18 | 2022 | 3502 | 1.650 |
Why?
|
| Heart Valves | 9 | 2019 | 291 | 1.470 |
Why?
|
| Blood Vessels | 8 | 2013 | 1124 | 1.430 |
Why?
|
| E-Selectin | 14 | 2012 | 579 | 1.420 |
Why?
|
| Cell Transdifferentiation | 4 | 2015 | 171 | 1.270 |
Why?
|
| Propranolol | 5 | 2022 | 502 | 1.230 |
Why?
|
| Pericytes | 7 | 2016 | 291 | 1.220 |
Why?
|
| Transforming Growth Factor beta | 10 | 2023 | 2006 | 1.090 |
Why?
|
| Sheep | 16 | 2022 | 1437 | 0.980 |
Why?
|
| Mice, Nude | 17 | 2021 | 3689 | 0.930 |
Why?
|
| Fetal Blood | 6 | 2014 | 1317 | 0.820 |
Why?
|
| Cells, Cultured | 35 | 2023 | 19223 | 0.810 |
Why?
|
| Cell Division | 13 | 2016 | 4564 | 0.800 |
Why?
|
| Angiopoietin-2 | 2 | 2021 | 170 | 0.800 |
Why?
|
| Tissue Engineering | 12 | 2013 | 1877 | 0.790 |
Why?
|
| Multipotent Stem Cells | 4 | 2010 | 183 | 0.780 |
Why?
|
| Glucose Transporter Type 1 | 4 | 2019 | 192 | 0.740 |
Why?
|
| Cell Differentiation | 19 | 2016 | 11470 | 0.740 |
Why?
|
| Cell Proliferation | 25 | 2016 | 10472 | 0.720 |
Why?
|
| Endothelium | 4 | 2022 | 778 | 0.710 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2019 | 1239 | 0.700 |
Why?
|
| Fibrin | 2 | 2013 | 506 | 0.700 |
Why?
|
| Myocardial Infarction | 8 | 2023 | 11690 | 0.690 |
Why?
|
| Collagen Type I | 2 | 2013 | 592 | 0.670 |
Why?
|
| Capillary Permeability | 1 | 2022 | 798 | 0.660 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 4 | 2013 | 495 | 0.650 |
Why?
|
| Cord Blood Stem Cell Transplantation | 2 | 2013 | 314 | 0.640 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2011 | 552 | 0.630 |
Why?
|
| Choroid Neoplasms | 1 | 2019 | 175 | 0.610 |
Why?
|
| Pulmonary Valve | 4 | 2010 | 437 | 0.610 |
Why?
|
| Mesoderm | 4 | 2011 | 686 | 0.610 |
Why?
|
| Hemangioma, Capillary | 3 | 2012 | 61 | 0.590 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 2 | 2018 | 139 | 0.580 |
Why?
|
| Choroid | 1 | 2019 | 317 | 0.580 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 9 | 2016 | 544 | 0.580 |
Why?
|
| Mitral Valve Insufficiency | 8 | 2019 | 1415 | 0.570 |
Why?
|
| Infant | 34 | 2021 | 35070 | 0.570 |
Why?
|
| Animals | 81 | 2023 | 168561 | 0.560 |
Why?
|
| Cell Communication | 5 | 2015 | 1619 | 0.550 |
Why?
|
| Losartan | 2 | 2017 | 298 | 0.540 |
Why?
|
| Peptides | 6 | 2013 | 4392 | 0.530 |
Why?
|
| Cell Adhesion | 12 | 2015 | 3139 | 0.500 |
Why?
|
| Insulin-Like Growth Factor II | 2 | 2008 | 271 | 0.500 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2015 | 686 | 0.490 |
Why?
|
| Integrin alpha6 | 1 | 2014 | 30 | 0.490 |
Why?
|
| Epoprostenol | 1 | 2015 | 254 | 0.490 |
Why?
|
| Angiopoietin-1 | 2 | 2013 | 114 | 0.480 |
Why?
|
| Signal Transduction | 18 | 2023 | 23387 | 0.480 |
Why?
|
| Paracrine Communication | 1 | 2015 | 276 | 0.460 |
Why?
|
| Sirolimus | 4 | 2015 | 1562 | 0.460 |
Why?
|
| Cell Adhesion Molecules | 7 | 2016 | 1599 | 0.460 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2016 | 1675 | 0.460 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 1525 | 0.450 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2015 | 282 | 0.450 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 3 | 2020 | 315 | 0.450 |
Why?
|
| Myofibroblasts | 1 | 2015 | 221 | 0.440 |
Why?
|
| Neoplastic Syndromes, Hereditary | 2 | 2012 | 241 | 0.440 |
Why?
|
| Mutation, Missense | 3 | 2019 | 2556 | 0.440 |
Why?
|
| Up-Regulation | 8 | 2021 | 4211 | 0.440 |
Why?
|
| Cell Movement | 15 | 2021 | 5212 | 0.430 |
Why?
|
| Mice | 42 | 2023 | 81045 | 0.430 |
Why?
|
| Extracellular Matrix | 3 | 2019 | 1740 | 0.410 |
Why?
|
| Muscles | 1 | 2017 | 1617 | 0.410 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2017 | 453 | 0.410 |
Why?
|
| Vasoconstriction | 1 | 2014 | 596 | 0.400 |
Why?
|
| Glucocorticoids | 2 | 2011 | 2107 | 0.390 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2014 | 3381 | 0.390 |
Why?
|
| Endothelial Growth Factors | 4 | 2002 | 694 | 0.390 |
Why?
|
| Ischemia | 3 | 2017 | 1911 | 0.380 |
Why?
|
| Neoplasm Proteins | 5 | 2019 | 3691 | 0.380 |
Why?
|
| Mutation | 12 | 2023 | 29717 | 0.380 |
Why?
|
| Endostatins | 3 | 2006 | 174 | 0.380 |
Why?
|
| Lymphokines | 4 | 2002 | 949 | 0.370 |
Why?
|
| Lymphatic Vessels | 1 | 2014 | 351 | 0.370 |
Why?
|
| Bioartificial Organs | 1 | 2010 | 49 | 0.370 |
Why?
|
| MAP Kinase Signaling System | 3 | 2015 | 1525 | 0.360 |
Why?
|
| RNA, Messenger | 18 | 2016 | 13029 | 0.360 |
Why?
|
| Laminin | 5 | 2014 | 418 | 0.360 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2015 | 1504 | 0.350 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2013 | 476 | 0.350 |
Why?
|
| Cattle | 12 | 2013 | 3923 | 0.350 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2023 | 644 | 0.350 |
Why?
|
| Calcium-Binding Proteins | 4 | 2016 | 1081 | 0.340 |
Why?
|
| Morphogenesis | 2 | 2011 | 752 | 0.340 |
Why?
|
| Dexamethasone | 3 | 2011 | 1949 | 0.330 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2018 | 2938 | 0.330 |
Why?
|
| Aortic Valve | 3 | 2015 | 1911 | 0.320 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 4 | 2008 | 664 | 0.320 |
Why?
|
| Skin Neoplasms | 6 | 2011 | 5662 | 0.320 |
Why?
|
| Humans | 106 | 2024 | 742088 | 0.320 |
Why?
|
| Proteoglycans | 4 | 2014 | 834 | 0.310 |
Why?
|
| Receptor, Notch1 | 2 | 2008 | 502 | 0.310 |
Why?
|
| Osteogenesis | 2 | 2015 | 1299 | 0.310 |
Why?
|
| Cell Separation | 6 | 2013 | 1749 | 0.310 |
Why?
|
| Ventricular Remodeling | 3 | 2017 | 1224 | 0.310 |
Why?
|
| Blood Cells | 2 | 2007 | 309 | 0.300 |
Why?
|
| Child, Preschool | 19 | 2021 | 40955 | 0.300 |
Why?
|
| Adipogenesis | 2 | 2010 | 358 | 0.300 |
Why?
|
| Angiogenesis Inhibitors | 5 | 2016 | 2038 | 0.300 |
Why?
|
| Down-Regulation | 5 | 2019 | 3001 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2015 | 2502 | 0.290 |
Why?
|
| Transfection | 7 | 2015 | 5892 | 0.280 |
Why?
|
| Smad3 Protein | 2 | 2018 | 180 | 0.270 |
Why?
|
| Neoplasm Regression, Spontaneous | 4 | 2009 | 46 | 0.270 |
Why?
|
| Vascular Neoplasms | 2 | 2007 | 175 | 0.270 |
Why?
|
| Coculture Techniques | 4 | 2015 | 1341 | 0.270 |
Why?
|
| GTP-Binding Protein alpha Subunits | 2 | 2017 | 100 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2015 | 8425 | 0.270 |
Why?
|
| Phenotype | 9 | 2021 | 16331 | 0.270 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 2043 | 0.260 |
Why?
|
| Arteriovenous Malformations | 2 | 2023 | 396 | 0.260 |
Why?
|
| Osteoblasts | 1 | 2010 | 1163 | 0.250 |
Why?
|
| NFATC Transcription Factors | 4 | 2010 | 380 | 0.250 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2018 | 480 | 0.250 |
Why?
|
| RNA Interference | 5 | 2015 | 2890 | 0.250 |
Why?
|
| Cell Lineage | 4 | 2015 | 2504 | 0.240 |
Why?
|
| Membrane Glycoproteins | 5 | 2016 | 3769 | 0.230 |
Why?
|
| Heart Valve Diseases | 1 | 2011 | 1067 | 0.230 |
Why?
|
| Platelet Membrane Glycoproteins | 2 | 1995 | 293 | 0.230 |
Why?
|
| Disease Models, Animal | 12 | 2019 | 18006 | 0.220 |
Why?
|
| Neuropilin-1 | 2 | 2014 | 90 | 0.220 |
Why?
|
| Bone Marrow Cells | 2 | 2008 | 2513 | 0.220 |
Why?
|
| Microscopy, Confocal | 4 | 2016 | 1969 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factors | 5 | 2009 | 772 | 0.210 |
Why?
|
| Genomic Imprinting | 1 | 2004 | 331 | 0.210 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 2059 | 0.210 |
Why?
|
| Phospholipase C beta | 1 | 2021 | 50 | 0.210 |
Why?
|
| Clone Cells | 5 | 2006 | 1692 | 0.200 |
Why?
|
| Atenolol | 1 | 2022 | 100 | 0.200 |
Why?
|
| NF-kappa B | 1 | 2010 | 2500 | 0.200 |
Why?
|
| Infant, Newborn | 11 | 2021 | 25575 | 0.200 |
Why?
|
| Collagen | 6 | 2017 | 2684 | 0.200 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 2009 | 599 | 0.200 |
Why?
|
| Vesicular Transport Proteins | 1 | 2024 | 377 | 0.200 |
Why?
|
| Cell Culture Techniques | 3 | 2011 | 1670 | 0.190 |
Why?
|
| Antigens, CD | 6 | 2015 | 4024 | 0.190 |
Why?
|
| HL-60 Cells | 5 | 2004 | 365 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 8 | 2015 | 6313 | 0.190 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2015 | 301 | 0.190 |
Why?
|
| Glycoproteins | 4 | 2004 | 2260 | 0.190 |
Why?
|
| Male | 37 | 2021 | 349538 | 0.190 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2001 | 130 | 0.190 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2020 | 83 | 0.190 |
Why?
|
| Atherosclerosis | 3 | 2023 | 3428 | 0.190 |
Why?
|
| Antineoplastic Agents | 3 | 2011 | 13655 | 0.190 |
Why?
|
| Selectins | 2 | 1997 | 102 | 0.180 |
Why?
|
| Echocardiography, Three-Dimensional | 4 | 2018 | 591 | 0.180 |
Why?
|
| Hypotrichosis | 1 | 2019 | 3 | 0.180 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 6608 | 0.180 |
Why?
|
| SOXF Transcription Factors | 1 | 2019 | 29 | 0.180 |
Why?
|
| Receptor, TIE-2 | 2 | 2015 | 178 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 4 | 2019 | 6171 | 0.170 |
Why?
|
| Protein Isoforms | 2 | 2016 | 1727 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 15494 | 0.170 |
Why?
|
| Transplantation, Heterologous | 3 | 2014 | 2382 | 0.170 |
Why?
|
| Telangiectasis | 1 | 2019 | 75 | 0.170 |
Why?
|
| Permeability | 1 | 2021 | 738 | 0.170 |
Why?
|
| Sesquiterpenes | 2 | 1998 | 175 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2003 | 4414 | 0.170 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 994 | 0.170 |
Why?
|
| P-Selectin | 5 | 2003 | 600 | 0.170 |
Why?
|
| Neoplasm Transplantation | 2 | 2014 | 2085 | 0.170 |
Why?
|
| Membrane Proteins | 3 | 2015 | 7873 | 0.170 |
Why?
|
| Papillary Muscles | 2 | 2017 | 200 | 0.170 |
Why?
|
| Phosphorylation | 4 | 2014 | 8436 | 0.160 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2010 | 933 | 0.160 |
Why?
|
| Child | 14 | 2021 | 77478 | 0.160 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 15108 | 0.160 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2019 | 428 | 0.160 |
Why?
|
| Plasminogen | 1 | 1998 | 152 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2018 | 118 | 0.160 |
Why?
|
| Microvessels | 2 | 2013 | 544 | 0.160 |
Why?
|
| Hindlimb | 2 | 2017 | 505 | 0.150 |
Why?
|
| Lymphangiogenesis | 1 | 2018 | 172 | 0.150 |
Why?
|
| Adaptation, Physiological | 5 | 2018 | 1310 | 0.150 |
Why?
|
| Organogenesis | 1 | 2018 | 222 | 0.150 |
Why?
|
| Flow Cytometry | 5 | 2016 | 5975 | 0.140 |
Why?
|
| Protein Kinase C | 1 | 2021 | 1227 | 0.140 |
Why?
|
| Atrial Function, Left | 1 | 2017 | 173 | 0.140 |
Why?
|
| Receptors, LDL | 1 | 2019 | 475 | 0.140 |
Why?
|
| Drug Combinations | 3 | 2014 | 1961 | 0.140 |
Why?
|
| Immunophenotyping | 2 | 2015 | 1866 | 0.140 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2016 | 142 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2001 | 3862 | 0.140 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 1998 | 692 | 0.140 |
Why?
|
| Oligosaccharides | 2 | 2001 | 414 | 0.140 |
Why?
|
| Myeloid Cells | 2 | 2019 | 804 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2016 | 89 | 0.130 |
Why?
|
| Skin Abnormalities | 1 | 2016 | 60 | 0.130 |
Why?
|
| Mice, SCID | 2 | 2011 | 2715 | 0.130 |
Why?
|
| Zebrafish | 2 | 2013 | 2990 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2015 | 10943 | 0.130 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 890 | 0.130 |
Why?
|
| Cadherins | 2 | 1997 | 906 | 0.130 |
Why?
|
| Biological Assay | 1 | 2018 | 652 | 0.130 |
Why?
|
| Polyglycolic Acid | 3 | 2010 | 406 | 0.130 |
Why?
|
| Culture Media, Conditioned | 2 | 2014 | 533 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 2712 | 0.130 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 3800 | 0.130 |
Why?
|
| Semaphorins | 1 | 2015 | 101 | 0.130 |
Why?
|
| Mannosidases | 2 | 1992 | 22 | 0.130 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2014 | 51 | 0.130 |
Why?
|
| Hyperplasia | 1 | 2018 | 1183 | 0.120 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2001 | 1659 | 0.120 |
Why?
|
| Gene Expression Regulation | 7 | 2016 | 12071 | 0.120 |
Why?
|
| Cell Survival | 4 | 2015 | 5872 | 0.120 |
Why?
|
| Bioprosthesis | 2 | 2010 | 596 | 0.120 |
Why?
|
| Blotting, Northern | 3 | 2003 | 1581 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 1792 | 0.120 |
Why?
|
| Rats | 5 | 2014 | 24265 | 0.120 |
Why?
|
| Female | 29 | 2021 | 379592 | 0.120 |
Why?
|
| Receptors, Angiotensin | 1 | 2014 | 142 | 0.120 |
Why?
|
| Rats, Nude | 1 | 2013 | 105 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2014 | 202 | 0.110 |
Why?
|
| Heparin | 1 | 2001 | 1636 | 0.110 |
Why?
|
| Zebrafish Proteins | 2 | 2013 | 1004 | 0.110 |
Why?
|
| Uveal Neoplasms | 1 | 2016 | 310 | 0.110 |
Why?
|
| Calcinosis | 2 | 2015 | 1497 | 0.110 |
Why?
|
| 1-Deoxynojirimycin | 1 | 1992 | 18 | 0.110 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1997 | 849 | 0.110 |
Why?
|
| Glycoconjugates | 1 | 1993 | 87 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2906 | 0.110 |
Why?
|
| Osteocalcin | 2 | 2010 | 273 | 0.110 |
Why?
|
| Blood Volume | 1 | 2014 | 565 | 0.110 |
Why?
|
| Macrophages | 3 | 2024 | 5655 | 0.110 |
Why?
|
| Lysophospholipids | 1 | 2015 | 331 | 0.110 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 4187 | 0.110 |
Why?
|
| Mannose | 1 | 1992 | 124 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 1655 | 0.110 |
Why?
|
| Lymphedema | 1 | 2019 | 528 | 0.110 |
Why?
|
| Integrins | 1 | 1997 | 845 | 0.110 |
Why?
|
| Models, Animal | 1 | 2019 | 2170 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 1416 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 489 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 1144 | 0.100 |
Why?
|
| Retinal Vessels | 2 | 2013 | 769 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2011 | 25 | 0.100 |
Why?
|
| Antibodies, Blocking | 1 | 2012 | 254 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 1121 | 0.100 |
Why?
|
| Hemodynamics | 2 | 2013 | 4197 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 504 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3564 | 0.100 |
Why?
|
| Podocytes | 1 | 2015 | 394 | 0.100 |
Why?
|
| Glycopeptides | 1 | 1992 | 224 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2019 | 1402 | 0.100 |
Why?
|
| Extremities | 1 | 2017 | 865 | 0.100 |
Why?
|
| Time Factors | 8 | 2017 | 40054 | 0.100 |
Why?
|
| Molecular Sequence Data | 7 | 2014 | 18112 | 0.100 |
Why?
|
| Epinephrine | 1 | 2014 | 793 | 0.100 |
Why?
|
| Lectins | 1 | 2013 | 514 | 0.100 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 643 | 0.100 |
Why?
|
| DNA | 3 | 2016 | 7289 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2014 | 3617 | 0.090 |
Why?
|
| Ultrasonography | 3 | 2013 | 5978 | 0.090 |
Why?
|
| Amino Acid Sequence | 6 | 2014 | 13814 | 0.090 |
Why?
|
| Adolescent | 10 | 2021 | 85649 | 0.090 |
Why?
|
| Proteins | 2 | 2004 | 6096 | 0.090 |
Why?
|
| Vasodilator Agents | 1 | 2014 | 976 | 0.090 |
Why?
|
| Rheology | 1 | 2011 | 345 | 0.090 |
Why?
|
| Transcription Factors | 3 | 2014 | 12164 | 0.090 |
Why?
|
| Random Allocation | 1 | 2014 | 2425 | 0.090 |
Why?
|
| Nuclear Proteins | 2 | 2002 | 5851 | 0.090 |
Why?
|
| Brain | 1 | 2016 | 26343 | 0.090 |
Why?
|
| Antibodies | 2 | 2015 | 2459 | 0.090 |
Why?
|
| Receptors, CXCR4 | 1 | 2014 | 726 | 0.090 |
Why?
|
| Apolipoproteins E | 3 | 2023 | 1438 | 0.090 |
Why?
|
| Peptide Fragments | 2 | 2001 | 5095 | 0.090 |
Why?
|
| Chondrogenesis | 1 | 2010 | 247 | 0.080 |
Why?
|
| Ovarian Neoplasms | 2 | 2016 | 4823 | 0.080 |
Why?
|
| Genes, Reporter | 1 | 2013 | 1547 | 0.080 |
Why?
|
| Perfusion | 1 | 2013 | 1359 | 0.080 |
Why?
|
| Mice, Knockout | 7 | 2020 | 14554 | 0.080 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2014 | 451 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 647 | 0.080 |
Why?
|
| Base Sequence | 5 | 2017 | 12797 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 2842 | 0.080 |
Why?
|
| Receptors, Cell Surface | 2 | 2015 | 2867 | 0.080 |
Why?
|
| Adult | 12 | 2021 | 213712 | 0.080 |
Why?
|
| Gene Expression | 3 | 2008 | 7790 | 0.080 |
Why?
|
| Injections | 1 | 2011 | 840 | 0.080 |
Why?
|
| Antigens, Nuclear | 1 | 2008 | 192 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 1221 | 0.080 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2003 | 707 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1158 | 0.080 |
Why?
|
| Protein Binding | 5 | 2020 | 9387 | 0.080 |
Why?
|
| Polyesters | 2 | 2010 | 363 | 0.070 |
Why?
|
| Feasibility Studies | 3 | 2013 | 5062 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 1887 | 0.070 |
Why?
|
| Cyclohexanes | 2 | 1998 | 152 | 0.070 |
Why?
|
| Antigens, Surface | 2 | 2008 | 1663 | 0.070 |
Why?
|
| Tissue Scaffolds | 2 | 2011 | 957 | 0.070 |
Why?
|
| Liver | 2 | 2014 | 7470 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2010 | 9639 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 1684 | 0.070 |
Why?
|
| Umbilical Veins | 1 | 2007 | 433 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 2088 | 0.070 |
Why?
|
| Skin | 4 | 2010 | 4353 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2008 | 477 | 0.070 |
Why?
|
| Dipeptides | 1 | 2008 | 409 | 0.070 |
Why?
|
| Adult Stem Cells | 1 | 2008 | 216 | 0.070 |
Why?
|
| Boronic Acids | 1 | 2010 | 965 | 0.070 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2006 | 75 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1372 | 0.070 |
Why?
|
| Granuloma, Pyogenic | 1 | 2006 | 48 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2010 | 2505 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2016 | 2940 | 0.070 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 944 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2006 | 162 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2002 | 5180 | 0.070 |
Why?
|
| Fibrosis | 3 | 2017 | 2026 | 0.070 |
Why?
|
| Alleles | 3 | 2016 | 6931 | 0.060 |
Why?
|
| Receptors, Notch | 1 | 2010 | 739 | 0.060 |
Why?
|
| Cell Line, Tumor | 4 | 2016 | 16665 | 0.060 |
Why?
|
| Age Factors | 2 | 2019 | 18355 | 0.060 |
Why?
|
| Ubiquitination | 2 | 2020 | 1011 | 0.060 |
Why?
|
| Regenerative Medicine | 1 | 2008 | 306 | 0.060 |
Why?
|
| HEK293 Cells | 3 | 2020 | 4200 | 0.060 |
Why?
|
| Sheep, Domestic | 2 | 2017 | 49 | 0.060 |
Why?
|
| Pyrazines | 1 | 2010 | 1231 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 1527 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 1990 | 1144 | 0.060 |
Why?
|
| Adrenal Cortex | 2 | 1996 | 139 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 3 | 2012 | 9274 | 0.060 |
Why?
|
| Chickens | 2 | 2015 | 865 | 0.060 |
Why?
|
| Aorta | 4 | 2020 | 2057 | 0.060 |
Why?
|
| Gene Deletion | 3 | 2020 | 2751 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 1899 | 0.060 |
Why?
|
| X Chromosome Inactivation | 1 | 2006 | 224 | 0.060 |
Why?
|
| Immunoglobulins | 2 | 1997 | 880 | 0.060 |
Why?
|
| Saphenous Vein | 1 | 2007 | 531 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2014 | 4143 | 0.060 |
Why?
|
| Antigens, Neoplasm | 2 | 2006 | 1983 | 0.060 |
Why?
|
| Lactic Acid | 2 | 2010 | 1132 | 0.060 |
Why?
|
| Infant Welfare | 1 | 2003 | 82 | 0.060 |
Why?
|
| Phthalazines | 1 | 2006 | 361 | 0.060 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2003 | 126 | 0.060 |
Why?
|
| Hydroxybutyrates | 1 | 2003 | 83 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2016 | 625 | 0.060 |
Why?
|
| Apoptosis | 2 | 2008 | 9715 | 0.060 |
Why?
|
| Transforming Growth Factors | 1 | 2023 | 76 | 0.060 |
Why?
|
| Molecular Imaging | 1 | 2010 | 831 | 0.060 |
Why?
|
| Protein Transport | 2 | 2010 | 1988 | 0.050 |
Why?
|
| Carbohydrate Sequence | 2 | 1993 | 414 | 0.050 |
Why?
|
| Aortic Valve Stenosis | 1 | 2015 | 1941 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 1618 | 0.050 |
Why?
|
| Ligands | 3 | 2014 | 3293 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4029 | 0.050 |
Why?
|
| Regeneration | 1 | 2011 | 1485 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2004 | 657 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4147 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 7721 | 0.050 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2023 | 185 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4465 | 0.050 |
Why?
|
| Absorbable Implants | 1 | 2004 | 342 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 1988 | 1423 | 0.050 |
Why?
|
| Polymers | 2 | 2010 | 1618 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 4933 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2008 | 1533 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2023 | 337 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2002 | 4322 | 0.050 |
Why?
|
| Adipocytes | 1 | 2008 | 1182 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2011 | 2968 | 0.050 |
Why?
|
| Syndecans | 1 | 2001 | 79 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 1997 | 1094 | 0.050 |
Why?
|
| Calcium | 3 | 2020 | 5753 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 11363 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2023 | 383 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 1486 | 0.050 |
Why?
|
| Kinetics | 2 | 2007 | 6474 | 0.050 |
Why?
|
| Cytokines | 3 | 2004 | 7317 | 0.050 |
Why?
|
| Polylysine | 1 | 2001 | 133 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2006 | 838 | 0.050 |
Why?
|
| Syndecan-1 | 1 | 2001 | 164 | 0.050 |
Why?
|
| Trypsin | 1 | 2001 | 509 | 0.050 |
Why?
|
| Contrast Media | 1 | 2013 | 5295 | 0.040 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2005 | 580 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2008 | 2739 | 0.040 |
Why?
|
| Microcirculation | 1 | 2004 | 1285 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2008 | 1911 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2003 | 1155 | 0.040 |
Why?
|
| Young Adult | 5 | 2020 | 56350 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2440 | 0.040 |
Why?
|
| Child Welfare | 1 | 2003 | 523 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2001 | 277 | 0.040 |
Why?
|
| Binding Sites | 2 | 2014 | 6115 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 5019 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2010 | 2723 | 0.040 |
Why?
|
| Fetus | 1 | 2006 | 1879 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1993 | 2837 | 0.040 |
Why?
|
| Angiostatins | 1 | 1998 | 67 | 0.040 |
Why?
|
| Bucladesine | 1 | 1998 | 121 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2002 | 2049 | 0.040 |
Why?
|
| Awards and Prizes | 1 | 2003 | 375 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 9410 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2018 | 126 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17400 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 1996 | 2211 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2003 | 2699 | 0.040 |
Why?
|
| Glycosaminoglycans | 1 | 2001 | 624 | 0.040 |
Why?
|
| Melanoma | 1 | 2016 | 5462 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2003 | 2615 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2007 | 2452 | 0.040 |
Why?
|
| Quail | 1 | 1997 | 40 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 1999 | 390 | 0.040 |
Why?
|
| Aged | 5 | 2021 | 162944 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2013 | 3731 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2018 | 317 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2017 | 21719 | 0.040 |
Why?
|
| Cross-Linking Reagents | 2 | 2012 | 694 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2023 | 879 | 0.040 |
Why?
|
| Models, Biological | 3 | 2018 | 9581 | 0.040 |
Why?
|
| Thoracic Surgery | 1 | 2003 | 713 | 0.030 |
Why?
|
| DNA Primers | 1 | 2001 | 2892 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2017 | 364 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 5 | 2015 | 21821 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 3504 | 0.030 |
Why?
|
| PPAR delta | 1 | 2015 | 43 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2004 | 1155 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2016 | 234 | 0.030 |
Why?
|
| Receptors, Cannabinoid | 1 | 2015 | 44 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 2018 | 551 | 0.030 |
Why?
|
| Neoplasms, Vascular Tissue | 1 | 2015 | 35 | 0.030 |
Why?
|
| Chorioallantoic Membrane | 1 | 2015 | 47 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 1889 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5724 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2015 | 210 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1996 | 293 | 0.030 |
Why?
|
| Chick Embryo | 1 | 1997 | 981 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2008 | 5019 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 354 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2015 | 742 | 0.030 |
Why?
|
| Angiogenic Proteins | 1 | 2014 | 104 | 0.030 |
Why?
|
| Pyridines | 1 | 2006 | 2818 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 1996 | 644 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2022 | 3557 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3847 | 0.030 |
Why?
|
| Swainsonine | 1 | 1992 | 10 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2016 | 391 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1993 | 218 | 0.030 |
Why?
|
| Culture Media | 1 | 2015 | 902 | 0.030 |
Why?
|
| Carbohydrate Conformation | 1 | 1992 | 208 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2015 | 607 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2014 | 472 | 0.030 |
Why?
|
| COS Cells | 1 | 2014 | 1160 | 0.030 |
Why?
|
| Immobilized Proteins | 1 | 2012 | 25 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1996 | 1470 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2014 | 462 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 1992 | 668 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 697 | 0.030 |
Why?
|
| Middle Aged | 7 | 2017 | 213127 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 791 | 0.030 |
Why?
|
| Alkaloids | 1 | 1992 | 190 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 1992 | 549 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 1402 | 0.030 |
Why?
|
| Cholesterol | 1 | 2020 | 2895 | 0.020 |
Why?
|
| alpha-Mannosidase | 1 | 1990 | 20 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 3770 | 0.020 |
Why?
|
| Veins | 1 | 2015 | 769 | 0.020 |
Why?
|
| Cell Cycle | 1 | 1999 | 2964 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2077 | 0.020 |
Why?
|
| Cell Shape | 1 | 2012 | 375 | 0.020 |
Why?
|
| Boston | 1 | 2003 | 9305 | 0.020 |
Why?
|
| Rabbits | 1 | 1997 | 4886 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 2699 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 427 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2003 | 4393 | 0.020 |
Why?
|
| Cell Death | 1 | 2015 | 1695 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2011 | 623 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1998 | 1825 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2003 | 3119 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 9735 | 0.020 |
Why?
|
| Placenta | 2 | 2010 | 1694 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 1086 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 21596 | 0.020 |
Why?
|
| Homeostasis | 1 | 2020 | 3335 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2191 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2016 | 3587 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 2723 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 2126 | 0.020 |
Why?
|
| Sensitivity and Specificity | 3 | 2011 | 14720 | 0.020 |
Why?
|
| Surface Properties | 1 | 2012 | 1182 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35342 | 0.020 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 1988 | 36 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2001 | 3678 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2008 | 121 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2014 | 3744 | 0.020 |
Why?
|
| Anisotropy | 1 | 2011 | 1265 | 0.020 |
Why?
|
| Collagen Type II | 1 | 2008 | 151 | 0.020 |
Why?
|
| Angiomatosis | 1 | 2007 | 49 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2011 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 2542 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2008 | 146 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2008 | 187 | 0.020 |
Why?
|
| Culture Techniques | 1 | 2008 | 554 | 0.020 |
Why?
|
| Retroviridae | 1 | 2010 | 914 | 0.020 |
Why?
|
| Cell Line | 2 | 1993 | 15994 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3584 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2010 | 784 | 0.020 |
Why?
|
| Osteopontin | 1 | 2008 | 296 | 0.020 |
Why?
|
| Osteocytes | 1 | 2008 | 197 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2010 | 926 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2008 | 553 | 0.020 |
Why?
|
| Umbilical Cord | 1 | 2007 | 180 | 0.020 |
Why?
|
| Prognosis | 2 | 2017 | 29010 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2015 | 1196 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 1585 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4839 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6756 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 11039 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2915 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 1801 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 641 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2008 | 865 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2017 | 3656 | 0.020 |
Why?
|
| Retina | 1 | 2015 | 2611 | 0.020 |
Why?
|
| Immunoassay | 1 | 1988 | 752 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2010 | 1159 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 4982 | 0.010 |
Why?
|
| Actins | 1 | 2011 | 2120 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4751 | 0.010 |
Why?
|
| Chondrocytes | 1 | 2008 | 803 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2008 | 2123 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 1152 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 839 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6365 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8297 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 57683 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2003 | 440 | 0.010 |
Why?
|
| Pregnancy | 2 | 2015 | 29087 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 913 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 962 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2016 | 6540 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10578 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2001 | 1386 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 1999 | 334 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 1999 | 385 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 6452 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2006 | 1731 | 0.010 |
Why?
|
| Graft Survival | 1 | 2008 | 3733 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1996 | 102 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1996 | 107 | 0.010 |
Why?
|
| Myocardium | 1 | 2009 | 4775 | 0.010 |
Why?
|
| Swine | 1 | 2006 | 5934 | 0.010 |
Why?
|
| Cornea | 1 | 2004 | 1497 | 0.010 |
Why?
|
| Leukocytes | 1 | 2004 | 2039 | 0.010 |
Why?
|
| Lung | 1 | 2014 | 9826 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1988 | 2211 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 1996 | 675 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 15530 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1988 | 4249 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 19862 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1999 | 2014 | 0.010 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2001 | 1384 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 72145 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1999 | 2455 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 77098 | 0.010 |
Why?
|
| Insulin | 1 | 1999 | 6575 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2007 | 62966 | 0.000 |
Why?
|